Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

Dezeen Showroom: from wellbeing-enhancing office pods to products that covertly control noise, the following pieces are ...

In vivo preclinicalproof-of-concept data presented at AHA and ESGCT demonstrating >90% LDL-C reduction in non-human primates supports ...

The market has since validated Guo’s conviction. On Kickstarter, Zettlab raised more than USD 1.4 million, with 80% of ...

Tech stocks and top consumer names are increasingly at risk of steep declines in a slowing economy. Click here to see 5 ...